54% of Mississippi's J&J recipients were white, while 37% were Black. Of the Johnson & Johnson doses administered to Mississippians, 54% went to women and 46% to men. The pause is temporary, Byers said, and MSDH will ensure providers who received shipments of Johnson & Johnson that haven't administered are maintaining the doses in conditions that keep them viable. Those thousands of doses won't go to waste.
MSDH has told providers not to distribute doses of the Johnson & Johnson vaccine until the CDC and its Advisory Committee distributes additional information on immunization practices. That's less than 3% of total doses administered in the state. Around 42,000 of those doses were Johnson & Johnson. Mississippi has administered about 1.477 million doses of the vaccine as of Tuesday. "And the relative risk of the vaccine, even with this horrible complication, is so much less common than death with COVID." "We're talking about a rare complication related to one of the three vaccines (Johnson & Johnson) that we have," Dobbs said. The CDC/FDA pause does not apply to the Pfizer and Moderna vaccines.
CDC PAUSES JOHNSON AND JOHNSON VACCINE HOW TO
MSDH will communicate with physicians, clinics and hospitals to advise them how to respond in the unlikely event that they see someone with this rare reaction, Dobbs said. None of the cases occurred in Mississippi, and the state has seen no severe adverse events related to the Johnson & Johnson vaccine, according to State Epidemiologist Dr. All six cases occurred six to 13 days after vaccination in women between the ages of 18 and 48.
The blood clots occurred in veins that drain blood from the brain and were seen in combination with low platelet levels.
The Johnson & Johnson vaccine is currently the only single-dose COVID-19 vaccine approved for use in the U.S. cases of a "rare type of blood clot" in individuals after receiving it. The pause in distribution and administration Johnson & Johnson's vaccine results from guidance issued by the Centers for Disease Control and Prevention and the Food and Drug Administration after six reported U.S. 13-TUPELO - The Mississippi State Department of Health is instructing physicians, clinics and hospitals to stop administering the Johnson and Johnson COVID-19 vaccine after reports of rare but potentially dangerous blood clots.
0 kommentar(er)
